SCHEMBL25825554

SCHEMBL25825554

CC(C)NS(=O)(=O)c1ccc(C(C)C)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
CHRNA7 P36544 1/20 0.43
ALDH1A1 P00352 7/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MEN1 O00255 1/20 0.41
GFER P55789 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CA9 Q16790 1/20 0.40
TSHR P16473 1/20 0.38
BRD4 O60885 1/20 0.38
NAMPT P43490 1/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13956958 0.81 KMT2A (0.45) KMT2AALDH1A1NPSR1MEN1GFER
SCHEMBL7916957 0.79 SMN1; SMN2 (0.58) KMT2AALDH1A1MEN1SMN1; SMN2POLB
SCHEMBL15573994 0.79 NPSR1 (0.42) KMT2AALDH1A1NPSR1MEN1GFER
SCHEMBL12414645 0.78 CHRNA7 (0.47) CHRNA7ALDH1A1SMN1; SMN2GAA
SCHEMBL20692252 0.78 CHRNA7 (0.42) KMT2ACHRNA7ALDH1A1SMN1; SMN2CA1
SCHEMBL16172616 0.77 ALDH1A1 (0.44) CHRNA7ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL15574004 0.77 KDM4E (0.63) KMT2AALDH1A1NPSR1MEN1GFER
SCHEMBL14299649 0.77 CHRNA7 (0.60) CHRNA7ALDH1A1CA12CA1CA2
SCHEMBL12695033 0.77 CHRNA7 (0.46) CHRNA7ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL15575098 0.76 SLC40A1 (0.49) KMT2AALDH1A1NPSR1MEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR KMT2A 3974/4885CHRNA7 4724/4885ALDH1A1 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.